Evaluation of correlation between dose and clinical outcomes in subcutaneous immunoglobulin replacement therapy
Clinical and Experimental Immunology, 05/07/2012
Orange JS et al. – The analyses indicate that certain clinical outcomes improve at higher SCIG doses and associated higher serum IgG concentrations and suggest that there might be opportunity to improve patient outcomes via SCIG dose adjustment.



